21690 results for «»
21690 results
Valve-in-valve TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.
Edge-to-edge mitral repair
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.
TAVI and coronary artery disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.
Update on new guidelines for management of patients with valvular heart disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on the management of patients with valvular heart disease to learn about the new guidelines, and discover how to apply them to your daily practice.
Bicuspid aortic valves: where do we stand?
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.
A case-based discussion on left atrial appendage closure
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this case-based session on left atrial appendage closure to learn more about patient selection and pre- / post-procedural planning for LAAO, and discover how to perform a safe and effective procedure.
Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.
Case-based challenging edge-to-edge mitral repair
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on mitral valve repair to learn how to successfully perform this procedure, especially in patients with challenging anatomies, and how to face any possible complications.
Case-based challenging TAVI
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations.
Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...
Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...
2021 Ethica Award: Dr. Marie-Claude Morice to receive the 2021 Andreas Grüntzig Ethica Award
17 May 2021
Paris, France, 10 May 2021 - EuroPCR, taking place online from 18 to 20 May 2021, will be an opportunity for the interventional cardiovascular community to come together and benefit from interactive training with their peers. At this year’s web-based event, Dr. Marie-Claude Morice will be presented with the Andreas...
30 years of Rotary ablation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Maurice Buchbinder to learn all about the history of rotary ablation, from its invention 30 years ago to its current practice, and discover various cases highlighting the results of this therapy.
EBC MAIN overview and the impact on clinical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith, Jens Flensted Lassen and Goran Stankovic in order to learn more about this important study and understand the impact to clinical practice, to gain insights from an interesting EBC main case, and to listen to the expert's perspectives on other recent...
Cool AMI EU pivotal trial- final results after trial discontinuation following ad interim analysis
18 May 2021
Results of the interim analyses performed after 12 months in the first 111 patients enrolled in phase II Cool AMI trial evaluating safety and effectiveness of systemic therapeutic hypothermia as an adjunctive therapy in anterior STEMI undergoing PCI as compared to PCI only. Analyses showed significant...
EBC MAIN trial results – what is new and what will change in left main stenting?
18 May 2021
The European Bifurcation Club Left Main (EBC MAIN) trial addressed the issue of provisional single stent versus upfront double stenting in 467 patients with true bifurcation distal left main disease.
So far, only one other randomized trial, DKCRUSH-V (n=482), has addressed the same research question, showing better...
A randomised trial comparing imaging-guided PCI with Orsiro vs Xience
18 May 2021
Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...
Authors :
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
One-year results from the FUTURE-II trial
18 May 2021
A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...
A new meta-analysis supports elective revascularization and medical therapy for reducing cardiac death
18 May 2021
The ISCHEMIA trial found no significant difference between an invasive vs. a conservative strategy in patients with chronic coronary syndromes and moderate to severe ischemia at a mean of 3.2 years. However, the cumulative difference in the estimates of cardiac death between the invasive and conservative...
